Stay updated on Ribociclib Efficacy After CDK4/6 Inhibit Progression Clinical Trial

Sign up to get notified when there's something new on the Ribociclib Efficacy After CDK4/6 Inhibit Progression Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ribociclib Efficacy After CDK4/6 Inhibit Progression Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page revision badge was updated from v3.5.2 to v3.5.3, indicating a minor update to the study record’s documentation or site content.
    Difference
    0.0%
    Check dated 2026-04-30T18:40:50.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Updated the page to revision v3.5.2 and removed the previous revision v3.5.0 from the change log.
    Difference
    0.0%
    Check dated 2026-04-16T10:43:02.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added on the page and Revision: v3.4.2 was removed. The trial details such as eligibility criteria, outcomes, and locations remain unchanged.
    Difference
    0.0%
    Check dated 2026-03-18T16:49:06.000Z thumbnail image
  6. Check
    90 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed earlier notices about funding and government operations (v3.4.1). No clinical trial content or eligibility criteria are affected.
    Difference
    0.4%
    Check dated 2026-02-11T09:25:06.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    Notice about a lapse in government funding is displayed, and the site revision has been updated to v3.4.1 (replacing v3.4.0). These changes are administrative and do not alter the study details or how users interact with the page.
    Difference
    0.4%
    Check dated 2026-02-04T05:48:06.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated metadata captions to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed the previous captions 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T04:17:43.000Z thumbnail image

Stay in the know with updates to Ribociclib Efficacy After CDK4/6 Inhibit Progression Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ribociclib Efficacy After CDK4/6 Inhibit Progression Clinical Trial page.